DXC008

· Hangzhou DAC Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DXC008, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors [Phase 1]